(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release →
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology, United Kingdom
Tagged Drew Burdon, EQT, EQT Life Sciences, investment, Mark Wyatt, Michael Sjöström, partnership, Phagenesis, Phagenyx, Reinhard Krickl, sustainability, Swallowing Disorder Treatment